Integrum, the medical technology company that provides the bone-anchored OPRA implant, appointed Victoria Boiko to coordinate the company’s commercial activities in Ukraine. The appointment comes as Ukraine’s Ministry of Health prepares a national pilot project to integrate osseointegration (OI) into the public healthcare system, a development that could expand access to the technology for those with amputations across the country.
She holds a master’s degree in international economics from Kyiv National Economic University and brings over 15 years of experience building business relationships between Ukraine and international partners.
She has worked across several Ukrainian industries in procurement, marketing, sales, and business development, both at distributors and at local partners of companies such as Bridgestone, Scania, and Oracle. At Integrum, Boiko will serve as a link to local partners, distributors, and institutional stakeholders in Ukraine, to strengthen the company’s capacity to support the planned expansion of OI treatments and position itself for growth as Ukraine moves toward systemic reimbursement. She will work with clinical and commercial teams to train surgeons and healthcare professionals, coordinate with local providers, and help navigate the evolving regulatory and reimbursement landscape.
“Ukraine’s ambition to make osseointegration part of its national healthcare system is a milestone—not only for the patients who benefit from the technology, but for the broader recognition of osseointegration as a standard of care. With the recruitment of Victoria Boiko, we are ensuring that Integrum has the right expertise at hand to support Ukrainian healthcare providers and patients during this critical phase. Deep knowledge of the local healthcare landscape will be essential as we work with our partners to make the OPRA Implant System accessible to more people in Ukraine,” Martin Hillsten, Integrum CEO said.
